Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Use of anakinra (Kineret) in the treatment of familial cold autoinflammatory syndrome with a 16-month follow-up.

Journal of cutaneous medicine and surgery - 1 Jan 2000

Ross J Barrie, Finlayson Laura A, Klotz P Jennifer, Langley Richard G, Gaudet Roxanne, Thompson Kara, Churchman Sarah M, McDermott Michael F, Hawkins Philip N

Abstract excerpt

BACKGROUND: The susceptibility gene for familial cold autoinflammatory syndrome (FCAS) has been mapped to chromosome 1q44 and a point mutation determined to be present in all affected members of a large Canadian kindred. Anakinra (Kineret) is known to block IL-1 receptor and in the few patients w...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antirheumatic Agents
Share to Autoimmune Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Canada

Share to Cold Temperature

Share to Inflammation

Share to Interleukin 1 Receptor Antagonist Protein

Share to Syndrome

Share to Urticaria

Source

Identifiers

PMID: 18258152
DOI: 10.2310/7750.2008.07050

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18258152-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Use of anakinra (Kineret) in the treatment of familial cold autoinflammatory syndrome with a 16-month follow-up.PMID 18258152Read ↗

Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist.Semantic proximity Read ↗

A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome.Semantic proximity Read ↗

"Mutation negative" familial cold autoinflammatory syndrome (FCAS) in an 8-year-old boy: clinical course and functional studies.Semantic proximity Read ↗

Familial cold auto-inflammatory syndrome (FCAS): characterization of symptomatology and impact on patients' lives.Semantic proximity Read ↗

Two pathogenic CIAS1 mutations and plasma cytokine profile in a Finnish patient with familial cold autoinflammatory syndrome responsive to anakinra.Semantic proximity Read ↗

New CIAS1 mutation and anakinra efficacy in overlapping of Muckle-Wells and familial cold autoinflammatory syndromes.Semantic proximity Read ↗

Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition.Semantic proximity Read ↗

A case of familial cold autoinflammatory syndrome confirmed by the presence of a CIAS1 mutation.Semantic proximity Read ↗

Familial cold autoinflammatory syndrome: Phenotype and genotype of an autosomal dominant periodic feverSemantic proximity Read ↗

Successful therapy with anakinra in a patient with generalized pustular psoriasis carrying IL36RN mutations.Semantic proximity Read ↗

Positive clinical and biochemical responses to anakinra in a 3-yr-old patient with cryopyrin-associated periodic syndrome (CAPS).Semantic proximity Read ↗

Efficacy and safety of canakinumab in cryopyrin-associated periodic syndromes: results from a Spanish cohort.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.